Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
09/27/16 4 Statement of changes in beneficial ownership of securities 1
09/27/16 4 Statement of changes in beneficial ownership of securities 1
09/27/16 4 Statement of changes in beneficial ownership of securities 1
09/23/16 8-K Current report filing
Documents
5
09/12/16 8-K Current report filing
Documents
24
08/25/16 8-K Current report filing
Documents
19
08/23/16 4 Statement of changes in beneficial ownership of securities 1
08/23/16 3 Initial statement of beneficial ownership of securities 2
08/18/16 8-K Current report filing
Documents
9
08/15/16 10-Q Quarterly report pursuant to Section 13 or 15(d) 27
RSS